The VersaTie posterior tensioning and supplemental fixation system offers a single dual locking connector designed for multiple surgical approaches from degenerative pathologies to complex deformities. The multi‐rod compatibility of the connector and the series of different band options affords surgeons maximum intraoperative flexibility.
VersaTie® is a posterior band system designed to provide clinical versatility and flexibility in the treatment of complex spinal pathologies in both adult and pediatric patients. The system provides primary and supplemental fixation options for patients where traditional fixation may not be feasible. VersaTie supports advanced spine translation techniques in adolescent idiopathic scoliosis (AIS) patients by providing controlled, hands-free translation. For adult deformity patients, VersaTie offers an advanced solution for distributed loading across the fixation hardware. The band system’s independent locking connector and advanced tensioning device offers enhanced control to address the variable needs of spine surgery.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company’s portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.